Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Retirement2's Profile
Displaying 151-200 of 613 result(s).
GNBTQ Generex Biotechnology Corp.
07/30/2021 8:32:47 AM
You are Correct.....Something is De (1)
GNBTQ Generex Biotechnology Corp.
07/29/2021 10:20:10 PM
A simple PR with an Update to the A (1)
GNBTQ Generex Biotechnology Corp.
07/28/2021 9:40:31 AM
Just throwing this out there becaus
GNBTQ Generex Biotechnology Corp.
07/26/2021 12:19:48 PM
3 song titles that this stock has p (2)
GNBTQ Generex Biotechnology Corp.
07/24/2021 9:27:01 AM
Nice find.....Totally Ageee.....not
GNBTQ Generex Biotechnology Corp.
07/22/2021 8:53:17 PM
Accepted and I'll even write for fr (2)
GNBTQ Generex Biotechnology Corp.
07/22/2021 8:14:01 PM
Will also ADD a Special PRAYER Also
GNBTQ Generex Biotechnology Corp.
07/22/2021 8:11:47 PM
My version of an Early 70's Classic (6)
GNBTQ Generex Biotechnology Corp.
07/22/2021 10:01:14 AM
Well put with insight....now I'll t (3)
GNBTQ Generex Biotechnology Corp.
07/21/2021 10:22:44 PM
I have now realized I am a Charter
GNBTQ Generex Biotechnology Corp.
07/21/2021 6:35:54 PM
Or maybe they wanted to start a fun
GNBTQ Generex Biotechnology Corp.
07/21/2021 6:32:28 PM
Hope they don't need the $$$ to set (3)
GNBTQ Generex Biotechnology Corp.
07/17/2021 6:44:39 AM
Last weekend Wasabi was kind enough (2)
GNBTQ Generex Biotechnology Corp.
07/17/2021 6:24:36 AM
Doc it's really not that bad if you
GNBTQ Generex Biotechnology Corp.
07/17/2021 5:47:34 AM
gnbt Shares increased by another 70 (1)
GNBTQ Generex Biotechnology Corp.
07/16/2021 11:18:07 AM
A Little insight, Thought & Humor.. (4)
GNBTQ Generex Biotechnology Corp.
07/13/2021 9:21:01 AM
Clear, Concise & to the Point..... (2)
GNBTQ Generex Biotechnology Corp.
07/08/2021 9:33:44 AM
Morning everyone.....just trolled t
GNBTQ Generex Biotechnology Corp.
07/06/2021 7:04:44 PM
Technically that share structure wa (1)
GNBTQ Generex Biotechnology Corp.
07/06/2021 9:38:17 AM
Understandable but that IZ the Expr (3)
GNBTQ Generex Biotechnology Corp.
07/06/2021 8:40:26 AM
Especially when it IZ TUESDAY the 6 (3)
GNBTQ Generex Biotechnology Corp.
06/22/2021 3:26:34 PM
There has been speculation of the R (3)
GNBTQ Generex Biotechnology Corp.
06/22/2021 2:58:43 PM
The easiest way to view this IMO is (1)
GNBTQ Generex Biotechnology Corp.
06/09/2021 8:53:23 AM
Had 2 come out of retirement for th (1)
GNBTQ Generex Biotechnology Corp.
05/21/2021 5:53:10 PM
Eyes will try my Best cuz the Beard (1)
GNBTQ Generex Biotechnology Corp.
05/21/2021 5:39:00 PM
Thanks DOCJ....got a Deer that walk (1)
GNBTQ Generex Biotechnology Corp.
05/21/2021 5:03:10 PM
Here are my Final Thoughts before I (2)
GNBTQ Generex Biotechnology Corp.
05/21/2021 1:23:08 PM
Wondering how much they are paying (2)
GNBTQ Generex Biotechnology Corp.
05/21/2021 9:30:07 AM
There is also Date errors in the Pr
GNBTQ Generex Biotechnology Corp.
05/21/2021 8:27:30 AM
Just the EZ WAY to Kick the Can and
GNBTQ Generex Biotechnology Corp.
05/21/2021 8:20:22 AM
Seen that post last night myself an
GNBTQ Generex Biotechnology Corp.
05/21/2021 1:13:53 AM
Are you referring to Wednesdays S1
GNBTQ Generex Biotechnology Corp.
05/19/2021 10:09:02 PM
So NGIO will be listed on the Pinks
GNBTQ Generex Biotechnology Corp.
05/19/2021 9:25:58 PM
Where and How A shares get their Va
GNBTQ Generex Biotechnology Corp.
05/19/2021 8:01:28 PM
Now would be a Great time for TC to
GNBTQ Generex Biotechnology Corp.
05/19/2021 7:57:00 PM
The one & only question I have is h
GNBTQ Generex Biotechnology Corp.
05/19/2021 12:02:50 PM
By NO means can you EVER hurt my fe (2)
GNBTQ Generex Biotechnology Corp.
05/19/2021 9:23:03 AM
Really....guess I picked the wrong (1)
GNBTQ Generex Biotechnology Corp.
05/19/2021 12:23:25 AM
And your point being.....why did yo (1)
GNBTQ Generex Biotechnology Corp.
05/18/2021 11:55:09 PM
He may have just come to stir thing
GNBTQ Generex Biotechnology Corp.
05/18/2021 10:11:43 AM
From my perspective HE is "OUR" gui
GNBTQ Generex Biotechnology Corp.
05/17/2021 9:36:34 AM
Just like Richard Dreyfuss in "Let (1)
GNBTQ Generex Biotechnology Corp.
05/13/2021 5:35:56 PM
I understand your point of view but
GNBTQ Generex Biotechnology Corp.
05/13/2021 2:59:40 PM
I feel the same Buildit.....if we t (1)
GNBTQ Generex Biotechnology Corp.
05/13/2021 11:41:15 AM
Understandable.....what 30 days in (1)
GNBTQ Generex Biotechnology Corp.
05/13/2021 11:09:09 AM
So much potential in "Coming DAZE". (3)
GNBTQ Generex Biotechnology Corp.
05/11/2021 6:51:08 PM
Thanks HY for the "TRIP" down Memor (3)
GNBTQ Generex Biotechnology Corp.
05/11/2021 9:46:23 AM
That is the same info I saw on Goog (1)
GNBTQ Generex Biotechnology Corp.
05/11/2021 9:26:01 AM
I think it may have been Buildit wh (2)
GNBTQ Generex Biotechnology Corp.
05/10/2021 9:30:01 AM
Like the PR....compact....straight (1)
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • Clay Heskett's Reelection Marks New Era for L.E.K. Consulting
  • Uni-Fuels H1 2025 Financial Highlights and Strategic Expansion
  • DataStrike's Dramatic Growth and the Shift to Onshore Support
  • NAPC Defense Gains Momentum in Global Tactical Systems Market
  • Skyline Bankshares Reports Impressive Q3 Earnings Growth
  • Winthrop Wealth Welcomes Mercer Asset Management Partner
  • Inseego Launches Innovative FX4200 Router for Enterprise 5G Access
  • Integral Molecular's Membrane Array Approaching FDA Status
  • Nautilus Biotechnology: Q3 Financial Review and Future Outlook
  • Clearmind Medicine's CEO Highlights Women's Role in Psychedelics
  • Revolutionary Blood Test by Mercy BioAnalytics for Ovarian Cancer
  • TeraWulf Releases Promising Financial Outlook for Q3 2025
  • QuickLogic Sets Conference Call for Q3 Fiscal Insights
  • Recursion's Upcoming Q3 2025 Financial Results and Insights
  • Kyle Busch and Samantha's Warning: Dangers of IUL Insurance
  • First Resource Bancorp Reports Impressive Q3 Growth Metrics
  • Essential Findings for Enhancing Resident Retention Efficiency
  • Sysco Corporation's Q1 2026 Performance Analysis and Insights
  • Piedmont Global Welcomes Mary Grothe as Chief Revenue Officer
  • MDClone Enhances Commitment to Canadian Healthcare Innovation
  • UPS Sets Record with Impressive Q3 Results and Strong Outlook
  • Grand Bay Hotel Joins Marriott Family for Enhanced Guest Experience
  • Evil Genius Games Partners with Living Dead Media for New Adventures
  • Cetera Financial Group's Innovative Wealth Management Solution
  • HydraVault Launches Advanced AI Facility Construction in Chicago
  • BLAZE Introduces Innovative AI Solutions for Cannabis Retail
  • Global Call to Action for Lennox-Gastaut Syndrome Awareness
  • AI Adoption in Automotive Deals: A Real-World Perspective
  • SharpLink Initiates $200M ETH Deployment Enhancing DeFi Yield
  • ProPhase Labs Strengthens Investor Engagement with RedChip
  • NANO Nuclear Energy Transforms to True North Nuclear for Growth
  • California BanCorp Achieves $15.7 Million Profit in Q3 2025
  • Medela Unveils Campaign to Celebrate Motherhood's Small Steps
  • VenHub Strengthens Position in Retail Automation by Joining NRF
  • Josh Ruben Joins the Board of PetVivo Holdings to Drive Growth
  • Newton Golf Expands E-Commerce with Japanese Market Site Launch
  • Innovative Gene Therapy SPVN20 Begins Patient Trials for Vision
  • Step Pharma Welcomes Dr. Karen Smith as New CMO to Innovate Cancer Care
  • Strategic Choices and Future Prospects for DEMIRE Real Estate
  • Independent Bank Corporation Announces Impressive Q3 Growth
  • VEON's JazzCash Secures Prestigious Silver Award in Lending
  • Context Therapeutics Announces Key Upcoming Investor Events
  • WeRide's CEO Lock-Up Enhances Shares Confidence During HKIPO
  • Nucor Corp Analysts Predict Strong Growth Amid Fluctuations
  • Recent Insights on Major Tech Stocks from CNBC's Trades
  • Strategic Sales Approach at DEMIRE to Boost Future Valuations
  • Cabinets To Go Launches Exciting New Showroom in Bowling Green
  • Odd Burger Terminates Placement Agreement Due to Default
  • FG Nexus Unveils Plans for Upcoming Conference in New York
  • D.R. Horton Faces Affordability Challenges as 2026 Approaches
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site